After decades of disappointment, efforts to create jabs that can stimulate the immune system to fight cancer are showing ...

A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49% ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Though it may seem like something from the future, these five cancer vaccines are available now. Here, more details on who is ...

Shares of Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) were up roughly 7% at $41, while those of Pfizer Inc (NYSE:PFE)were up nearly ...

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme. The new results from ...

Similarly, allogenic vaccines from whole tumor cells of multiple melanoma lines have been developed. Some of the most impressive results with vaccine therapy were seen in a retrospective review ...

After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

An important trial of the world's first "personalised" mRNA vaccine against the deadliest form of skin cancer - melanoma - is now under way in the UK. Steve Young, 52, from Stevenage, Herts ...